Variation in the human soluble epoxide hydrolase gene and risk of restenosis after percutaneous coronary intervention

被引:11
作者
Kullmann, Silke [1 ]
Binner, Priska [1 ]
Rackebrandt, Kirsten [1 ]
Huge, Andreas [2 ]
Haltern, Georg [3 ]
Lankisch, Mark [3 ]
Fueth, Reiner [3 ]
von Hodenberg, Eberhard [4 ]
Bestehorn, Hans-Peter [5 ]
Scheffold, Thomas [1 ]
机构
[1] Univ Witten Herdecke, Inst Heart & Circulat Res, D-44227 Dortmund, Germany
[2] Univ Munster, Leibniz Inst Arteriosclerosis Res, D-48149 Munster, Germany
[3] Wuppertal Helios Kliniken, Ctr Heart, D-42117 Wuppertal, Germany
[4] Heart Ctr Lahr Baden, D-77933 Lahr, Germany
[5] Heart Ctr Bad Krozingen, D-79189 Bad Krozingen, Germany
来源
BMC CARDIOVASCULAR DISORDERS | 2009年 / 9卷
关键词
EPOXYGENASE-DERIVED EICOSANOIDS; BLOOD-PRESSURE REGULATION; EPOXYEICOSATRIENOIC ACIDS; 20-HYDROXYEICOSATETRAENOIC ACID; SEQUENCE VARIATION; ANGIOPLASTY; DISEASE; POLYMORPHISMS; INHIBITION; PREVENTION;
D O I
10.1186/1471-2261-9-48
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Restenosis represents the major limiting factor for the long-term efficacy of percutaneous coronary intervention (PCI). Several genetic factors involved in the regulation of the vascular system have been described to play a role in the pathogenesis of restenosis. We investigated whether the EPHX2 K55R polymorphism, previously linked to significantly higher risk for coronary heart disease (CHD), was associated with the occurrence of restenosis after PCI. The association with incident CHD should have been confirmed and a potential correlation of the EPHX2 K55R variant to an increased risk of hypertension was analysed. Methods: An overall cohort of 706 patients was studied: This cohort comprised of 435 CHD patients who had undergone successful PCI. Follow-up coronary angiography in all patients was performed 6 months after intervention. Another 271 patients in whom CHD had been excluded by coronary angiography served as controls. From each patient EDTA-blood was drawn at the baseline ward round. Genomic DNA was extracted from these samples and genotyping was performed by real-time PCR and subsequent melting curve analysis. Results: In CHD patients 6 month follow-up coronary angiography revealed a restenosis rate of 29.4%, classified as late lumen loss as well as lumen re-narrowing >= 50%. Statistical analysis showed an equal genotype distribution in restenosis patients and non-restenosis patients (A/A 82.0% and A/G + G/G 18.0% versus A/A 82.1% and A/G + G/G 17.9%). Moreover, neither a significant difference in the genotype distribution of CHD patients and controls nor an association with increased risk of hypertension was found. Conclusion: The results of the present study indicate that the EPHX2 K55R polymorphism is not associated with restenosis after PCI, with incidence of CHD, or with an increased risk of hypertension and therefore, can not serve as a predictor for risk of CHD or restenosis after PCI.
引用
收藏
页数:7
相关论文
共 36 条
[1]   Evaluation of the effect of oral verapamil on clinical outcome and angiographic -: Restenosis after percutaneous coronary intervention -: The randomized, double-blind, placebo-controlled, multicenter verapamil slow-release for prevention of cardiovascular events after angioplasty (VESPA) trial [J].
Bestehorn, HP ;
Neumann, FJ ;
Büttner, HJ ;
Betz, P ;
Stürzenhofecker, P ;
von Hodenberg, E ;
Verdun, A ;
Levai, L ;
Monassier, JP ;
Roskamm, H .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (12) :2160-2165
[2]   Genetic analysis of the soluble epoxide hydrolase gene, EPHX2, in subclinical cardiovascular disease in the Diabetes Heart Study [J].
Burdon, Kathryn P. ;
Lehtinen, Allison B. ;
Langefeld, Carl D. ;
Carr, J. Jeffrey ;
Rich, Stephen S. ;
Freedman, Barry I. ;
Herrington, David ;
Bowden, Donald W. .
DIABETES & VASCULAR DISEASE RESEARCH, 2008, 5 (02) :128-134
[3]   New role for epoxyeicosatrienoic acids as anti-inflammatory mediators [J].
Campbell, WB .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2000, 21 (04) :125-127
[4]   Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors [J].
Campbell, WB ;
Gebremedhin, D ;
Pratt, PF ;
Harder, DR .
CIRCULATION RESEARCH, 1996, 78 (03) :415-423
[5]   Impact of smoking on clinical and angiographic restenosis after percutaneous coronary intervention - Another smoker's paradox? [J].
Cohen, DJ ;
Doucet, M ;
Cutlip, DE ;
Ho, KKL ;
Popma, JJ ;
Kuntz, RE .
CIRCULATION, 2001, 104 (07) :773-778
[6]   Altered soluble epoxide hydrolase gene expression and function and vascular disease risk in the stroke-prone spontaneously hypertensive rat [J].
Corenblum, Mandi J. ;
Wise, Vance E. ;
Georgi, Katrin ;
Hammock, Bruce D. ;
Doris, Peter A. ;
Fornage, Myriam .
HYPERTENSION, 2008, 51 (02) :567-573
[7]   Effect of soluble epoxide hydrolase inhibition on epoxyeicosatrienoic acid metabolism in human blood vessels [J].
Fang, X ;
Weintraub, NL ;
McCaw, RB ;
Hu, SM ;
Harmon, SD ;
Rice, JB ;
Hammock, BD ;
Spector, AA .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2004, 287 (06) :H2412-H2420
[8]   Drug-eluting stents in vascular intervention [J].
Fattori, R ;
Piva, T .
LANCET, 2003, 361 (9353) :247-249
[9]   The soluble epoxide hydrolase gene harbors sequence variation associated with susceptibility to and protection from incident ischemic stroke [J].
Fornage, M ;
Lee, CR ;
Doris, PA ;
Bray, MS ;
Heiss, G ;
Zeldin, DC ;
Boerwinkle, E .
HUMAN MOLECULAR GENETICS, 2005, 14 (19) :2829-2837
[10]   Polymorphism in soluble epoxide hydrolase and blood pressure in spontaneously hypertensive rats [J].
Fornage, M ;
Hinojos, CA ;
Nurowska, BW ;
Boerwinkle, E ;
Hammock, BD ;
Morisseau, CHP ;
Doris, PA .
HYPERTENSION, 2002, 40 (04) :485-490